Literature DB >> 18182216

Participation of kallikrein-kinin system in different pathologies.

Claudio M Costa-Neto1, Patrícia Dillenburg-Pilla, Tassiele A Heinrich, Lucas T Parreiras-e-Silva, Marilia G A G Pereira, Rosana I Reis, Pedro P C Souza.   

Abstract

The general description of kinins refers to these peptides as molecules involved in vascular tone regulation and inflammation. Nevertheless, in the last years a series of evidences has shown that local hormonal systems, such as the kallikrein-kinin system, may be differently regulated and are of pivotal importance to pathophysiological control. The combined interpretations of many recent studies allow us to conclude that the kallikrein-kinin system plays broader and richer roles than those classically described until recently. In this review, we report findings concerning the participation of the kallikrein-kinin system in inflammation, cancer, and in pathologies related to cardiovascular, renal and central nervous systems.

Entities:  

Mesh:

Year:  2007        PMID: 18182216     DOI: 10.1016/j.intimp.2007.08.003

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  23 in total

Review 1.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

2.  Analysis of heart rate signals during meditation using visibility graph complexity.

Authors:  Mahda Nasrolahzadeh; Zeynab Mohammadpoory; Javad Haddadnia
Journal:  Cogn Neurodyn       Date:  2018-08-27       Impact factor: 5.082

3.  Kinin B2 receptor does not exert renoprotective effects on mice with glycerol-induced rhabdomyolysis.

Authors:  Pedro Paulo Gattai; Fernando Francisco Pazello Mafra; Frederick Wasinski; Sandro Soares Almeida; Marcos Antônio Cenedeze; Denise Maria Avancini Costa Malheiros; Reury Frank Pereira Bacurau; Carlos Castilho Barros; Niels Olsen Saraiva Câmara; Ronaldo Carvalho Araujo
Journal:  World J Nephrol       Date:  2014-08-06

Review 4.  Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

Authors:  Amaly Nokkari; Hadi Abou-El-Hassan; Yehia Mechref; Stefania Mondello; Mark S Kindy; Ayad A Jaffa; Firas Kobeissy
Journal:  Prog Neurobiol       Date:  2018-01-31       Impact factor: 11.685

Review 5.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

6.  Blockade of the kinin B1 receptor affects the cytokine/chemokine profile in rat brain subjected to autoimmune encephalomyelitis.

Authors:  Karolina Podsiadło; Grzegorz Sulkowski; Beata Dąbrowska-Bouta; Lidia Strużyńska
Journal:  Inflammopharmacology       Date:  2017-02-03       Impact factor: 4.473

7.  Inflammatory muscle pain is dependent on the activation of kinin B₁ and B₂ receptors and intracellular kinase pathways.

Authors:  F C Meotti; R Campos; Kabs da Silva; A F Paszcuk; R Costa; J B Calixto
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

8.  Distinct kinin-induced functions are altered in circulating cells of young type 1 diabetic patients.

Authors:  Nicolle Kränkel; Stephen Paul Armstrong; Craig Alexander McArdle; Colin Dayan; Paolo Madeddu
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

9.  B1 and B2 kinin receptor blockade improves psoriasis-like disease.

Authors:  Bruna da Silva Soley; Leonardo Martins Silva; Daniel Augusto Gasparin Bueno Mendes; André Báfica; João Bosco Pesquero; Michael Bader; Deborah A Witherden; Wendy L Havran; João B Calixto; Michel Fleith Otuki; Daniela Almeida Cabrini
Journal:  Br J Pharmacol       Date:  2020-05-30       Impact factor: 8.739

10.  Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway.

Authors:  Yiou Wang; Bingxue Zhang; Yibing Huang; Wenjun Yao; Fei Tao; Yuxin Chen
Journal:  Molecules       Date:  2021-06-26       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.